Public Employees Retirement Association of Colorado’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.27M | Buy |
208,471
+194,650
| +1,408% | +$4.28M | 0.02% | 420 |
|
|
2026
Q1 | $308K | Hold |
13,821
| – | – | ﹤0.01% | 1238 |
|
|
2025
Q4 | $369K | Hold |
13,821
| – | – | ﹤0.01% | 1137 |
|
|
2025
Q3 | $295K | Hold |
13,821
| – | – | ﹤0.01% | 1252 |
|
|
2025
Q2 | $298K | Hold |
13,821
| – | – | ﹤0.01% | 1239 |
|
|
2025
Q1 | $230K | Hold |
13,821
| – | – | ﹤0.01% | 1366 |
|
|
2024
Q4 | $254K | Hold |
13,821
| – | – | ﹤0.01% | 1384 |
|
|
2024
Q3 | $213K | Hold |
13,821
| – | – | ﹤0.01% | 1500 |
|
|
2024
Q2 | $225K | Sell |
13,821
-1,527
| -10% | -$24.6K | ﹤0.01% | 1429 |
|
|
2024
Q1 | $284K | Sell |
15,348
-133
| -0.9% | -$3.29K | ﹤0.01% | 1327 |
|
|
2023
Q4 | $485K | Sell |
15,481
-1,853
| -11% | -$44.3K | ﹤0.01% | 1021 |
|
|
2023
Q3 | $361K | Sell |
17,334
-999
| -5% | -$27.1K | ﹤0.01% | 1156 |
|
|
2023
Q2 | $439K | Hold |
18,333
| – | – | ﹤0.01% | 1112 |
|
|
2023
Q1 | $345K | Hold |
18,333
| – | – | ﹤0.01% | 1264 |
|
|
2022
Q4 | $292K | Hold |
18,333
| – | – | ﹤0.01% | 1401 |
|
|
2022
Q3 | $300K | Hold |
18,333
| – | – | ﹤0.01% | 1344 |
|
|
2022
Q2 | $258K | Hold |
18,333
| – | – | ﹤0.01% | 1474 |
|
|
2022
Q1 | $444K | Hold |
18,333
| – | – | ﹤0.01% | 1201 |
|
|
2021
Q4 | $428K | Hold |
18,333
| – | – | ﹤0.01% | 1356 |
|
|
2021
Q3 | $305K | Hold |
18,333
| – | – | ﹤0.01% | 1539 |
|
|
2021
Q2 | $447K | Hold |
18,333
| – | – | ﹤0.01% | 1314 |
|
|
2021
Q1 | $473K | Hold |
18,333
| – | – | ﹤0.01% | 1221 |
|
|
2020
Q4 | $980K | Hold |
18,333
| – | – | ﹤0.01% | 758 |
|
|
2020
Q3 | $756K | Hold |
18,333
| – | – | ﹤0.01% | 790 |
|
|
2020
Q2 | $889K | Hold |
18,333
| – | – | 0.01% | 703 |
|
|
2020
Q1 | $775K | Hold |
18,333
| – | – | 0.01% | 689 |
|
|
2019
Q4 | $784K | Hold |
18,333
| – | – | ﹤0.01% | 796 |
|
|
2019
Q3 | $660K | Hold |
18,333
| – | – | ﹤0.01% | 880 |
|
|
2019
Q2 | $490K | Hold |
18,333
| – | – | ﹤0.01% | 1057 |
|
|
2019
Q1 | $492K | Hold |
18,333
| – | – | ﹤0.01% | 1053 |
|
|
2018
Q4 | $296K | Hold |
18,333
| – | – | ﹤0.01% | 1295 |
|
|
2018
Q3 | $381K | Hold |
18,333
| – | – | ﹤0.01% | 1297 |
|
|
2018
Q2 | $280K | Sell |
18,333
-3,723
| -17% | -$66.4K | ﹤0.01% | 1451 |
|
|
2018
Q1 | $496K | Buy |
22,056
+7
| +0% | +$194 | ﹤0.01% | 1079 |
|
|
2017
Q4 | $664K | Buy |
22,049
+679
| +3% | +$21.7K | ﹤0.01% | 993 |
|
|
2017
Q3 | $805K | Hold |
21,370
| – | – | 0.01% | 881 |
|
|
2017
Q2 | $596K | Buy |
21,370
+4
| +0% | +$119 | ﹤0.01% | 1035 |
|
|
2017
Q1 | $735K | Sell |
21,366
-39
| -0.2% | -$1.38K | 0.01% | 932 |
|
|
2016
Q4 | $617K | Sell |
21,405
-11
| -0.1% | -$291 | ﹤0.01% | 1022 |
|
|
2016
Q3 | $681K | Sell |
21,416
-949
| -4% | -$32.2K | 0.01% | 953 |
|
|
2016
Q2 | $726K | Buy |
22,365
+914
| +4% | +$30.6K | 0.01% | 934 |
|
|
2016
Q1 | $600K | Buy |
21,451
+1,596
| +8% | +$34.8K | ﹤0.01% | 1044 |
|
|
2015
Q4 | $708K | Hold |
19,855
| – | – | 0.01% | 951 |
|
|
2015
Q3 | $657K | Hold |
19,855
| – | – | 0.01% | 1018 |
|
|
2015
Q2 | $832K | Sell |
19,855
-3,685
| -16% | -$143K | 0.01% | 986 |
|
|
2015
Q1 | $767K | Hold |
23,540
| – | – | 0.01% | 1040 |
|
|
2014
Q4 | $747K | Sell |
23,540
-7,024
| -23% | -$199K | 0.01% | 1051 |
|
|
2014
Q3 | $757K | Hold |
30,564
| – | – | 0.01% | 1031 |
|
|
2014
Q2 | $690K | Buy |
+30,564
| New | +$638K | 0.01% | 1112 |
|
Other funds holding ACAD
N
Public Employees Retirement Association of Colorado's ACAD Position: Q2 2026 in Review
Public Employees Retirement Association of Colorado increased its Acadia Pharmaceuticals (ACAD) stake by 1,408% in Q2 2026, buying an estimated $4.28M and bringing the position to 208,471 shares worth $5.27M. The position accounts for 0.02% of the portfolio, ranked #420.
Public Employees Retirement Association of Colorado first reported a position in ACAD in Q2 2014 and has held it in 49 quarters since. 186 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.
- Public Employees Retirement Association of Colorado held 208,471 shares of Acadia Pharmaceuticals worth $5.27M as of Q2 2026.
- Public Employees Retirement Association of Colorado bought 194,650 Acadia Pharmaceuticals shares in Q2 2026, an estimated $4.28M.
- Acadia Pharmaceuticals made up 0.02% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #420 holding.
- Public Employees Retirement Association of Colorado first reported a position in Acadia Pharmaceuticals in Q2 2014 and has held it in 49 quarters since.
- 186 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.
Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.